{
    "abstract": "Leishmaniasis is an arthropod vectored disease causing considerable human morbidity and mortality. Vaccination remains the most realistic and practical means to interrupt the growing number and diversity of sand fly vectors and reservoirs of Leishmania. Since transmission of Leishmania is achieved exclusively by sand fly vectors via immune-modulating salivary substances, conventional vaccination requiring an unmodified host immune response for success are potentially destined to fail unless immunomodulatory factors are somehow neutralized. Using cationic liposome DNA complexes (CLDC) as an adjuvant system along with Lu. longipalpis sand fly salivary component maxadilan (MAX) as antigen (Ag), we show that mice are protected from the MAX-induced exacerbation of infection with Leishmania major (Lm). The CLDC adjuvant and alum were comparable in terms of lesion induration and decreased parasite burden, however the alum adjuvant imposed more inflammation at the injection site. BALB/c, C3H and C57BL/6 mice vaccinated with MAX-CLDC containing either the full-length MAX or peptides spanning the N- and C-terminal regions of MAX are protected against footpad challenges with Lm co-injected with MAX. When compared to unvaccinated controls, all strains of mice immunized with CLDC containing either peptides encompassing the first 20 N-terminal AA or those spanning the last 15 AA of the C-terminal domain of MAX demonstrated decreased parasite burden after 9 or 18 weeks post challenge with Lm + MAX. MAX-CLDC immunized mice showed increased IFN\u03b3-secreting and decreased IL-4-secreting CD4+ cells in footpad-draining lymph nodes. Antisera from C-terminal peptide (P11) MAX-CLDC-vaccinated animals was capable of recognizing FL-MAX and its C-terminal domain and also blocked MAX-mediated reprogramming of bone marrow-derived dendritic cells (BM-DC) in vitro. This peptide vaccine targeting sand fly MAX, improves host immunity against MAX-mediated immunomodulation.",
    "author_highlights": [
        {
            "endOffset": 24688,
            "sentence": "Vaccination against maxadilan (MAX) protect mice from aggravated Leishmania infection.",
            "startOffset": 24602
        },
        {
            "endOffset": 24783,
            "sentence": "Vaccination against MAX increases the number of IFN-\u03b3-producing cells in draining lymph nodes.",
            "startOffset": 24689
        },
        {
            "endOffset": 24875,
            "sentence": "The peptide MAX-CLDC vaccine improves host immunity against MAX-mediated immune modulation.",
            "startOffset": 24784
        }
    ],
    "bib_entries": {
        "b0005": null,
        "b0010": {
            "authors": [
                {
                    "first": "Jos\u00e9 M.C.",
                    "initial": "J.M.C.",
                    "last": "Ribeiro"
                },
                {
                    "first": "Oren",
                    "initial": "O.",
                    "last": "Katz"
                },
                {
                    "first": "Lewis K.",
                    "initial": "L.K.",
                    "last": "Pannell"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Waitumbi"
                },
                {
                    "first": "Alon",
                    "initial": "A.",
                    "last": "Warburg"
                }
            ],
            "firstpage": "1551",
            "issn": "00220949",
            "lastpage": "1559",
            "pmid": "10229701",
            "pub_year": 1999,
            "title": "Salivary glands of the sand fly Phlebotomus papatasi contain pharmacologically active amounts of adenosine and 5'-AMP",
            "volume": "202"
        },
        "b0015": {
            "authors": [
                {
                    "first": "Jos\u00e9 M.C.",
                    "initial": "J.M.C.",
                    "last": "Ribeiro"
                },
                {
                    "first": "Ivo M.B.",
                    "initial": "I.M.B.",
                    "last": "Francischetti"
                }
            ],
            "doi": "10.1146/annurev.ento.48.060402.102812",
            "firstpage": "73",
            "issn": "00664170",
            "lastpage": "88",
            "pmid": "12194906",
            "pub_year": 2003,
            "title": "Role of Arthropod Saliva in Blood Feeding: Sialome and Post-Sialome Perspectives",
            "volume": "48"
        },
        "b0020": {
            "authors": [
                {
                    "first": "William H.",
                    "initial": "W.H.",
                    "last": "Wheat"
                },
                {
                    "first": "Kristen E.",
                    "initial": "K.E.",
                    "last": "Pauken"
                },
                {
                    "first": "Robin V.",
                    "initial": "R.V.",
                    "last": "Morris"
                },
                {
                    "first": "Richard G.",
                    "initial": "R.G.",
                    "last": "Titus"
                }
            ],
            "doi": "10.4049/jimmunol.180.12.8286",
            "firstpage": "8286",
            "issn": "00221767",
            "lastpage": "8298",
            "pmid": "18523295",
            "pub_year": 2008,
            "title": "Lutzomyia longipalpis salivary peptide maxadilan alters murine dendritic cell expression of CD80/86, CCR7, and cytokine secretion and reprograms dendritic cell-mediated cytokine release from cultures containing allogeneic T cells",
            "volume": "180"
        },
        "b0025": {
            "authors": [
                {
                    "first": "Fabiano",
                    "initial": "F.",
                    "last": "Oliveira"
                },
                {
                    "first": "Augusto M.",
                    "initial": "A.M.",
                    "last": "de Carvalho"
                },
                {
                    "first": "Camila I.",
                    "initial": "C.I.",
                    "last": "de Oliveira"
                }
            ],
            "doi": "10.3389/fimmu.2013.00375",
            "issn": "16643224",
            "pub_year": 2013,
            "title": "Sand-fly saliva-Leishmania-man: The trigger trio",
            "volume": "4"
        },
        "b0030": {
            "authors": [
                {
                    "first": "S. G.",
                    "initial": "S.G.",
                    "last": "Reed"
                },
                {
                    "first": "R. N.",
                    "initial": "R.N.",
                    "last": "Coler"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Mondal"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Kamhawi"
                },
                {
                    "first": "J. G.",
                    "initial": "J.G.",
                    "last": "Valenzuela"
                }
            ],
            "doi": "10.1586/14760584.2016.1105135",
            "firstpage": "81",
            "issn": "14760584",
            "lastpage": "90",
            "pmid": "26595093",
            "pub_year": 2016,
            "title": "Leishmania vaccine development: Exploiting the host-vector-parasite interface",
            "volume": "15"
        },
        "b0035": {
            "authors": [
                {
                    "first": "Jorge",
                    "initial": "J.",
                    "last": "Alvar"
                },
                {
                    "first": "Simon L.",
                    "initial": "S.L.",
                    "last": "Croft"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Kaye"
                },
                {
                    "first": "Ali",
                    "initial": "A.",
                    "last": "Khamesipour"
                },
                {
                    "first": "Shyam",
                    "initial": "S.",
                    "last": "Sundar"
                },
                {
                    "first": "Steven G.",
                    "initial": "S.G.",
                    "last": "Reed"
                }
            ],
            "doi": "10.1016/j.vaccine.2012.11.080",
            "firstpage": "B244",
            "issn": "0264410X",
            "lastpage": "B249",
            "pmid": "23598489",
            "pub_year": 2013,
            "title": "Case study for a vaccine against leishmaniasis",
            "volume": "31"
        },
        "b0040": {
            "authors": [
                {
                    "first": "Rajeev",
                    "initial": "R.",
                    "last": "Nagill"
                },
                {
                    "first": "Sukhbir",
                    "initial": "S.",
                    "last": "Kaur"
                }
            ],
            "doi": "10.1016/j.intimp.2011.05.008",
            "firstpage": "1464",
            "issn": "15675769",
            "lastpage": "1488",
            "pmid": "21616175",
            "pub_year": 2011,
            "title": "Vaccine candidates for leishmaniasis: A review",
            "volume": "11"
        },
        "b0045": {
            "authors": [
                {
                    "first": "Coreen M.",
                    "initial": "C.M.",
                    "last": "Beaumier"
                },
                {
                    "first": "Portia M.",
                    "initial": "P.M.",
                    "last": "Gillespie"
                },
                {
                    "first": "Peter J.",
                    "initial": "P.J.",
                    "last": "Hotez"
                },
                {
                    "first": "Maria Elena",
                    "initial": "M.E.",
                    "last": "Bottazzi"
                }
            ],
            "doi": "10.1016/j.trsl.2013.03.006",
            "firstpage": "144",
            "issn": "19315244",
            "lastpage": "155",
            "pub_year": 2013,
            "title": "New vaccines for neglected parasitic diseases and dengue",
            "volume": "162"
        },
        "b0050": {
            "authors": [
                {
                    "first": "R. V.",
                    "initial": "R.V.",
                    "last": "Morris"
                },
                {
                    "first": "C. B.",
                    "initial": "C.B.",
                    "last": "Shoemaker"
                },
                {
                    "first": "J. R.",
                    "initial": "J.R.",
                    "last": "David"
                },
                {
                    "first": "G. C.",
                    "initial": "G.C.",
                    "last": "Lanzaro"
                },
                {
                    "first": "R. G.",
                    "initial": "R.G.",
                    "last": "Titus"
                }
            ],
            "doi": "10.4049/jimmunol.167.9.5226",
            "firstpage": "5226",
            "issn": "00221767",
            "lastpage": "5230",
            "pmid": "11673536",
            "pub_year": 2001,
            "title": "Sandfly maxadilan exacerbates infection with Leishmania major and vaccinating against it protects against L. major infection",
            "volume": "167"
        },
        "b0055": {
            "authors": [
                {
                    "first": "R. G.",
                    "initial": "R.G.",
                    "last": "Titus"
                },
                {
                    "first": "G. C.",
                    "initial": "G.C.",
                    "last": "Lima"
                },
                {
                    "first": "H. D.",
                    "initial": "H.D.",
                    "last": "Engers"
                },
                {
                    "first": "J. A.",
                    "initial": "J.A.",
                    "last": "Louis"
                }
            ],
            "firstpage": "1594",
            "issn": "00221767",
            "lastpage": "1600",
            "pmid": "6205088",
            "pub_year": 1984,
            "title": "Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity",
            "volume": "133"
        },
        "b0060": null,
        "b0065": {
            "authors": [
                {
                    "first": "G. C.",
                    "initial": "G.C.",
                    "last": "Lanzaro"
                },
                {
                    "first": "A. H.C.S.",
                    "initial": "A.H.C.S.",
                    "last": "Lopes"
                },
                {
                    "first": "J. M.C.",
                    "initial": "J.M.C.",
                    "last": "Ribeiro"
                },
                {
                    "first": "C. B.",
                    "initial": "C.B.",
                    "last": "Shoemaker"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Warburg"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Scares"
                },
                {
                    "first": "R. G.",
                    "initial": "R.G.",
                    "last": "Titus"
                }
            ],
            "doi": "10.1046/j.1365-2583.1999.820267.x",
            "firstpage": "267",
            "issn": "09621075",
            "lastpage": "275",
            "pmid": "10380110",
            "pub_year": 1999,
            "title": "Variation in the salivary peptide, maxadilan, from species in the Lutzomyia longipalpis complex",
            "volume": "8"
        },
        "b0070": {
            "authors": [
                {
                    "first": "Hermerio C.",
                    "initial": "H.C.",
                    "last": "Lima"
                },
                {
                    "first": "Julie A.",
                    "initial": "J.A.",
                    "last": "Bleyenberg"
                },
                {
                    "first": "Richard G.",
                    "initial": "R.G.",
                    "last": "Titus"
                }
            ],
            "doi": "10.1016/S0169-4758(96)40010-2",
            "firstpage": "80",
            "issn": "01694758",
            "lastpage": "82",
            "pub_year": 1997,
            "title": "A simple method for quantifying Leishmania in tissues of infected animals",
            "volume": "13"
        },
        "b0075": {
            "authors": [
                {
                    "first": "Nancy Smyth",
                    "initial": "N.S.",
                    "last": "Templeton"
                },
                {
                    "first": "Danilo D.",
                    "initial": "D.D.",
                    "last": "Lasic"
                },
                {
                    "first": "Peter M.",
                    "initial": "P.M.",
                    "last": "Frederik"
                },
                {
                    "first": "Helmut H.",
                    "initial": "H.H.",
                    "last": "Strey"
                },
                {
                    "first": "David D.",
                    "initial": "D.D.",
                    "last": "Roberts"
                },
                {
                    "first": "George N.",
                    "initial": "G.N.",
                    "last": "Pavlakis"
                }
            ],
            "doi": "10.1038/nbt0797-647",
            "firstpage": "647",
            "issn": "10870156",
            "lastpage": "652",
            "pmid": "9219267",
            "pub_year": 1997,
            "title": "Improved DNA: Liposome complexes for increased systemic delivery and gene expression",
            "volume": "15"
        },
        "b0080": {
            "authors": [
                {
                    "first": "Karen",
                    "initial": "K.",
                    "last": "Zaks"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Jordan"
                },
                {
                    "first": "Amanda",
                    "initial": "A.",
                    "last": "Guth"
                },
                {
                    "first": "Karen",
                    "initial": "K.",
                    "last": "Sellins"
                },
                {
                    "first": "Ross",
                    "initial": "R.",
                    "last": "Kedl"
                },
                {
                    "first": "Angelo",
                    "initial": "A.",
                    "last": "Izzo"
                },
                {
                    "first": "Catharine",
                    "initial": "C.",
                    "last": "Bosio"
                },
                {
                    "first": "Steven",
                    "initial": "S.",
                    "last": "Dow"
                }
            ],
            "doi": "10.4049/jimmunol.176.12.7335",
            "firstpage": "7335",
            "issn": "00221767",
            "lastpage": "7345",
            "pmid": "16751377",
            "pub_year": 2006,
            "title": "Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes",
            "volume": "176"
        },
        "b0085": {
            "authors": [
                {
                    "first": "Anuraj H.",
                    "initial": "A.H.",
                    "last": "Shankar"
                },
                {
                    "first": "Richard G.",
                    "initial": "R.G.",
                    "last": "Titus"
                }
            ],
            "doi": "10.1084/jem.181.3.845",
            "firstpage": "845",
            "issn": "00221007",
            "lastpage": "855",
            "pmid": "7869047",
            "pub_year": 1995,
            "title": "T cell and non-T cell compartments can independently determine resistance to leishmania major",
            "volume": "181"
        },
        "b0090": {
            "authors": [
                {
                    "first": "John S.",
                    "initial": "J.S.",
                    "last": "Spencer"
                },
                {
                    "first": "Hee Jin",
                    "initial": "H.J.",
                    "last": "Kim"
                },
                {
                    "first": "Angela M.",
                    "initial": "A.M.",
                    "last": "Marques"
                },
                {
                    "first": "Mercedes",
                    "initial": "M.",
                    "last": "Gonzalez-Juarerro"
                },
                {
                    "first": "Monica C.B.S.",
                    "initial": "M.C.B.S.",
                    "last": "Lima"
                },
                {
                    "first": "Varalakshmi D.",
                    "initial": "V.D.",
                    "last": "Vissa"
                },
                {
                    "first": "Richard W.",
                    "initial": "R.W.",
                    "last": "Truman"
                },
                {
                    "first": "Maria Laura",
                    "initial": "M.L.",
                    "last": "Gennaro"
                },
                {
                    "first": "Sang Nae",
                    "initial": "S.N.",
                    "last": "Cho"
                },
                {
                    "first": "Stewart T.",
                    "initial": "S.T.",
                    "last": "Cole"
                },
                {
                    "first": "Patrick J.",
                    "initial": "P.J.",
                    "last": "Brennan"
                }
            ],
            "doi": "10.1128/IAI.72.6.3161-3170.2004",
            "firstpage": "3161",
            "issn": "00199567",
            "lastpage": "3170",
            "pmid": "15155617",
            "pub_year": 2004,
            "title": "Comparative analysis of B- and T-cell epitopes of Mycobacterium leprae and Mycobacterium tuberculosis culture filtrate protein 10",
            "volume": "72"
        },
        "b0095": {
            "authors": [
                {
                    "first": "Kayo",
                    "initial": "K.",
                    "last": "Inba"
                },
                {
                    "first": "Muneo",
                    "initial": "M.",
                    "last": "Inaba"
                },
                {
                    "first": "Nikolaus",
                    "initial": "N.",
                    "last": "Romani"
                },
                {
                    "first": "Hideki",
                    "initial": "H.",
                    "last": "Aya"
                },
                {
                    "first": "Masashi",
                    "initial": "M.",
                    "last": "Deguchi"
                },
                {
                    "first": "Susumu",
                    "initial": "S.",
                    "last": "Ikehara"
                },
                {
                    "first": "Shigeru",
                    "initial": "S.",
                    "last": "Muramatsu"
                },
                {
                    "first": "Ralph M.",
                    "initial": "R.M.",
                    "last": "Steinman"
                }
            ],
            "doi": "10.1084/jem.176.6.1693",
            "firstpage": "1693",
            "issn": "00221007",
            "lastpage": "1702",
            "pmid": "1460426",
            "pub_year": 1992,
            "title": "Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor",
            "volume": "176"
        },
        "b0100": {
            "authors": [
                {
                    "first": "Osamu",
                    "initial": "O.",
                    "last": "Moro"
                },
                {
                    "first": "Ethan A.",
                    "initial": "E.A.",
                    "last": "Lerner"
                }
            ],
            "doi": "10.1074/jbc.272.2.966",
            "firstpage": "966",
            "issn": "00219258",
            "lastpage": "970",
            "pmid": "8995389",
            "pub_year": 1997,
            "title": "Maxadilan, the vasodilator from sand flies, is a specific pituitary adenylate cyclase activating peptide type I receptor agonist",
            "volume": "272"
        },
        "b0105": {
            "authors": [
                {
                    "first": "Osamu",
                    "initial": "O.",
                    "last": "Moro"
                },
                {
                    "first": "Kaori",
                    "initial": "K.",
                    "last": "Wakita"
                },
                {
                    "first": "Manami",
                    "initial": "M.",
                    "last": "Ohnuma"
                },
                {
                    "first": "Sumiko",
                    "initial": "S.",
                    "last": "Denda"
                },
                {
                    "first": "Ethan A.",
                    "initial": "E.A.",
                    "last": "Lerner"
                },
                {
                    "first": "Masahiro",
                    "initial": "M.",
                    "last": "Tajima"
                }
            ],
            "doi": "10.1074/jbc.274.33.23103",
            "firstpage": "23103",
            "issn": "00219258",
            "lastpage": "23110",
            "pmid": "10438479",
            "pub_year": 1999,
            "title": "Functional characterization of structural alterations in the sequence of the vasodilatory peptide maxadilan yields a pituitary adenylate cyclase- activating peptide type 1 receptor-specific antagonist",
            "volume": "274"
        },
        "b0110": {
            "authors": [
                {
                    "first": "Tess M.",
                    "initial": "T.M.",
                    "last": "Brodie"
                },
                {
                    "first": "Matthew C.",
                    "initial": "M.C.",
                    "last": "Smith"
                },
                {
                    "first": "Robin V.",
                    "initial": "R.V.",
                    "last": "Morris"
                },
                {
                    "first": "Richard G.",
                    "initial": "R.G.",
                    "last": "Titus"
                }
            ],
            "doi": "10.1128/IAI.01812-06",
            "firstpage": "2359",
            "issn": "00199567",
            "lastpage": "2365",
            "pmid": "17339357",
            "pub_year": 2007,
            "title": "Immunomodulatory effects of the Lutzomyia longipalpis salivary gland protein maxadilan on mouse macrophages",
            "volume": "75"
        },
        "b0115": {
            "authors": [
                {
                    "first": "Jeanette V.",
                    "initial": "J.V.",
                    "last": "Bishop"
                },
                {
                    "first": "J. Santiago",
                    "initial": "J.S.",
                    "last": "Mejia"
                },
                {
                    "first": "Adalberto A.",
                    "initial": "A.A.",
                    "last": "P\u00e9rez De Le\u00f3n"
                },
                {
                    "first": "Walter J.",
                    "initial": "W.J.",
                    "last": "Tabachnick"
                },
                {
                    "first": "Richard G.",
                    "initial": "R.G.",
                    "last": "Titus"
                }
            ],
            "firstpage": "532",
            "issn": "00029637",
            "lastpage": "536",
            "pmid": "16968936",
            "pub_year": 2006,
            "title": "Salivary gland extracts of Culicoides sonorensis inhibit murine lymphocyte proliferation and no production by macrophages",
            "volume": "75"
        },
        "b0120": {
            "authors": [
                {
                    "first": "Dirceu J.",
                    "initial": "D.J.",
                    "last": "Costa"
                },
                {
                    "first": "Cec\u00edlia",
                    "initial": "C.",
                    "last": "Favali"
                },
                {
                    "first": "Jorge",
                    "initial": "J.",
                    "last": "Clar\u00eancio"
                },
                {
                    "first": "L\u00edlian",
                    "initial": "L.",
                    "last": "Afonso"
                },
                {
                    "first": "Viviane",
                    "initial": "V.",
                    "last": "Concei\u00e7\u00e3o"
                },
                {
                    "first": "Jos\u00e9 Carlos",
                    "initial": "J.C.",
                    "last": "Miranda"
                },
                {
                    "first": "Richard G.",
                    "initial": "R.G.",
                    "last": "Titus"
                },
                {
                    "first": "Jesus",
                    "initial": "J.",
                    "last": "Valenzuela"
                },
                {
                    "first": "Manoel",
                    "initial": "M.",
                    "last": "Barral-Netto"
                },
                {
                    "first": "Aldina",
                    "initial": "A.",
                    "last": "Barral"
                },
                {
                    "first": "Cl\u00e1udia Ida",
                    "initial": "C.I.",
                    "last": "Brodskyn"
                }
            ],
            "doi": "10.1128/IAI.72.3.1298-1305.2004",
            "firstpage": "1298",
            "issn": "00199567",
            "lastpage": "1305",
            "pmid": "14977931",
            "pub_year": 2004,
            "title": "Lutzomyia longipalpis Salivary Gland Homogenate Impairs Cytokine Production and Costimulatory Molecule Expression on Human Monocytes and Dendritic Cells",
            "volume": "72"
        },
        "b0125": {
            "authors": [
                {
                    "first": "Nicola",
                    "initial": "N.",
                    "last": "Kimblin"
                },
                {
                    "first": "Nathan",
                    "initial": "N.",
                    "last": "Peters"
                },
                {
                    "first": "Alain",
                    "initial": "A.",
                    "last": "Debrabant"
                },
                {
                    "first": "Nagila",
                    "initial": "N.",
                    "last": "Secundino"
                },
                {
                    "first": "Jackson",
                    "initial": "J.",
                    "last": "Egen"
                },
                {
                    "first": "Phillip",
                    "initial": "P.",
                    "last": "Lawyer"
                },
                {
                    "first": "Michael P.",
                    "initial": "M.P.",
                    "last": "Fay"
                },
                {
                    "first": "Shaden",
                    "initial": "S.",
                    "last": "Kamhawi"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Sacks"
                }
            ],
            "doi": "10.1073/pnas.0802331105",
            "firstpage": "10125",
            "issn": "00278424",
            "lastpage": "10130",
            "pmid": "18626016",
            "pub_year": 2008,
            "title": "Quantification of the infectious dose of Leishmania major transmitted to the skin by single sand flies",
            "volume": "105"
        },
        "b0130": {
            "authors": [
                {
                    "first": "Matthew E.",
                    "initial": "M.E.",
                    "last": "Rogers"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Ilg"
                },
                {
                    "first": "Andrei V.",
                    "initial": "A.V.",
                    "last": "Nikolaev"
                },
                {
                    "first": "Michael A.J.",
                    "initial": "M.A.J.",
                    "last": "Ferguson"
                },
                {
                    "first": "Paul A.",
                    "initial": "P.A.",
                    "last": "Bates"
                }
            ],
            "doi": "10.1038/nature02675",
            "firstpage": "463",
            "issn": "00280836",
            "lastpage": "467",
            "pmid": "15269771",
            "pub_year": 2004,
            "title": "Transmission of cutaneous leishmaniasis by sand flies is enhanced by regurgitation of fPPG",
            "volume": "430"
        },
        "b0135": {
            "authors": [
                {
                    "first": "Richard G.",
                    "initial": "R.G.",
                    "last": "Titus"
                },
                {
                    "first": "Jos\u00e9 M.C.",
                    "initial": "J.M.C.",
                    "last": "Ribeiro"
                }
            ],
            "doi": "10.1126/science.3344436",
            "firstpage": "1306",
            "issn": "00368075",
            "lastpage": "1308",
            "pmid": "3344436",
            "pub_year": 1988,
            "title": "Salivary gland lysates from the sand fly lutzomyia longipalpis enhance leishmania infectivity",
            "volume": "239"
        },
        "b0140": null,
        "b0145": {
            "authors": [
                {
                    "first": "M. Lamine",
                    "initial": "M.L.",
                    "last": "Mbow"
                },
                {
                    "first": "Julie A.",
                    "initial": "J.A.",
                    "last": "Bleyenberg"
                },
                {
                    "first": "Laurie R.",
                    "initial": "L.R.",
                    "last": "Hall"
                },
                {
                    "first": "Richard G.",
                    "initial": "R.G.",
                    "last": "Titus"
                }
            ],
            "firstpage": "5571",
            "issn": "00221767",
            "lastpage": "5577",
            "pmid": "9820534",
            "pub_year": 1998,
            "title": "Phlebotomus papatasi sand fly salivary gland lysate down-regulates a Th1, but up-regulates a Th2, response in mice infected with Leishmania major",
            "volume": "161"
        },
        "b0150": {
            "authors": [
                {
                    "first": "C. M.",
                    "initial": "C.M.",
                    "last": "Theodos"
                },
                {
                    "first": "J. M.C.",
                    "initial": "J.M.C.",
                    "last": "Ribeiro"
                },
                {
                    "first": "R. G.",
                    "initial": "R.G.",
                    "last": "Titus"
                }
            ],
            "firstpage": "1592",
            "issn": "00199567",
            "lastpage": "1598",
            "pmid": "2019430",
            "pub_year": 1991,
            "title": "Analysis of enhancing effect of sand fly saliva on Leishmania infection in mice",
            "volume": "59"
        },
        "b0155": {
            "authors": [
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Warburg"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Saraiva"
                },
                {
                    "first": "G. C.",
                    "initial": "G.C.",
                    "last": "Lanzaro"
                },
                {
                    "first": "R. G.",
                    "initial": "R.G.",
                    "last": "Titus"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Neva"
                }
            ],
            "doi": "10.1098/rstb.1994.0097",
            "firstpage": "223",
            "issn": "09628436",
            "lastpage": "230",
            "pmid": "7972360",
            "pub_year": 1994,
            "title": "Saliva of Lutzomyia longipalpis sibling species differs in its composition and capacity to enhance leishmaniasis",
            "volume": "345"
        },
        "b0160": {
            "authors": [
                {
                    "first": "Nilufer B.",
                    "initial": "N.B.",
                    "last": "Norsworthy"
                },
                {
                    "first": "Jiaren",
                    "initial": "J.",
                    "last": "Sun"
                },
                {
                    "first": "Dia",
                    "initial": "D.",
                    "last": "Elnaiem"
                },
                {
                    "first": "Gregory",
                    "initial": "G.",
                    "last": "Lanzaro"
                },
                {
                    "first": "Lynn",
                    "initial": "L.",
                    "last": "Soong"
                }
            ],
            "doi": "10.1128/IAI.72.3.1240-1247.2004",
            "firstpage": "1240",
            "issn": "00199567",
            "lastpage": "1247",
            "pmid": "14977924",
            "pub_year": 2004,
            "title": "Sand Fly Saliva Enhances Leishmania amazonensis Infection by Modulating Interleukin-10 Production",
            "volume": "72"
        },
        "b0165": {
            "authors": [
                {
                    "first": "Oren",
                    "initial": "O.",
                    "last": "Katz"
                },
                {
                    "first": "John N.",
                    "initial": "J.N.",
                    "last": "Waitumbi"
                },
                {
                    "first": "Ronnie",
                    "initial": "R.",
                    "last": "Zer"
                },
                {
                    "first": "Alon",
                    "initial": "A.",
                    "last": "Warburg"
                }
            ],
            "doi": "10.4269/ajtmh.2000.62.145",
            "firstpage": "145",
            "issn": "00029637",
            "lastpage": "150",
            "pmid": "10761741",
            "pub_year": 2000,
            "title": "Adenosine, AMP, and protein phosphatase activity in sandfly saliva",
            "volume": "62"
        },
        "b0170": {
            "authors": [
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Waitumbi"
                },
                {
                    "first": "Alon",
                    "initial": "A.",
                    "last": "Warburg"
                }
            ],
            "firstpage": "1534",
            "issn": "00199567",
            "lastpage": "1537",
            "pmid": "9529078",
            "pub_year": 1998,
            "title": "Phlebotomus papatasi Saliva Inhibits Protein Phosphatase Activity and Nitric Oxide Production by Murine Macrophages",
            "volume": "66"
        },
        "b0175": {
            "authors": [
                {
                    "first": "J. G.",
                    "initial": "J.G.",
                    "last": "Valenzuela"
                },
                {
                    "first": "Y.",
                    "initial": "Y.",
                    "last": "Belkaid"
                },
                {
                    "first": "M. K.",
                    "initial": "M.K.",
                    "last": "Garfield"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Mendez"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Kamhawi"
                },
                {
                    "first": "E. D.",
                    "initial": "E.D.",
                    "last": "Rowton"
                },
                {
                    "first": "D. L.",
                    "initial": "D.L.",
                    "last": "Sacks"
                },
                {
                    "first": "J. M.C.",
                    "initial": "J.M.C.",
                    "last": "Ribeiro"
                }
            ],
            "doi": "10.1084/jem.194.3.331",
            "firstpage": "331",
            "issn": "00221007",
            "lastpage": "342",
            "pmid": "11489952",
            "pub_year": 2001,
            "title": "Toward a defined anti-Leishmania vaccine targeting vector antigens: Characterization of a protective salivary protein",
            "volume": "194"
        },
        "b0180": {
            "authors": [
                {
                    "first": "Regis",
                    "initial": "R.",
                    "last": "Gomes"
                },
                {
                    "first": "Fabiano",
                    "initial": "F.",
                    "last": "Oliveira"
                },
                {
                    "first": "Clarissa",
                    "initial": "C.",
                    "last": "Teixeira"
                },
                {
                    "first": "Claudio",
                    "initial": "C.",
                    "last": "Meneses"
                },
                {
                    "first": "Dana C.",
                    "initial": "D.C.",
                    "last": "Gilmore"
                },
                {
                    "first": "Dia Eldin",
                    "initial": "D.E.",
                    "last": "Elnaiem"
                },
                {
                    "first": "Shaden",
                    "initial": "S.",
                    "last": "Kamhawi"
                },
                {
                    "first": "Jesus G.",
                    "initial": "J.G.",
                    "last": "Valenzuela"
                }
            ],
            "doi": "10.1038/jid.2012.205",
            "firstpage": "2735",
            "issn": "0022202X",
            "lastpage": "2743",
            "pmid": "22739793",
            "pub_year": 2012,
            "title": "Immunity to sand fly salivary protein LJM11 modulates host response to vector-transmitted leishmania conferring ulcer-free protection",
            "volume": "132"
        },
        "b0185": {
            "authors": [
                {
                    "first": "Fabiano",
                    "initial": "F.",
                    "last": "Oliveira"
                },
                {
                    "first": "Edgar",
                    "initial": "E.",
                    "last": "Rowton"
                },
                {
                    "first": "Hamide",
                    "initial": "H.",
                    "last": "Aslan"
                },
                {
                    "first": "Regis",
                    "initial": "R.",
                    "last": "Gomes"
                },
                {
                    "first": "Philip A.",
                    "initial": "P.A.",
                    "last": "Castrovinci"
                },
                {
                    "first": "Patricia H.",
                    "initial": "P.H.",
                    "last": "Alvarenga"
                },
                {
                    "first": "Maha",
                    "initial": "M.",
                    "last": "Abdeladhim"
                },
                {
                    "first": "Clarissa",
                    "initial": "C.",
                    "last": "Teixeira"
                },
                {
                    "first": "Claudio",
                    "initial": "C.",
                    "last": "Meneses"
                },
                {
                    "first": "Lindsey T.",
                    "initial": "L.T.",
                    "last": "Kleeman"
                },
                {
                    "first": "Anderson B.",
                    "initial": "A.B.",
                    "last": "Guimar\u00e3es-Costa"
                },
                {
                    "first": "Tobin E.",
                    "initial": "T.E.",
                    "last": "Rowland"
                },
                {
                    "first": "Dana",
                    "initial": "D.",
                    "last": "Gilmore"
                },
                {
                    "first": "Seydou",
                    "initial": "S.",
                    "last": "Doumbia"
                },
                {
                    "first": "Steven G.",
                    "initial": "S.G.",
                    "last": "Reed"
                },
                {
                    "first": "Phillip G.",
                    "initial": "P.G.",
                    "last": "Lawyer"
                },
                {
                    "first": "John F.",
                    "initial": "J.F.",
                    "last": "Andersen"
                },
                {
                    "first": "Shaden",
                    "initial": "S.",
                    "last": "Kamhawi"
                },
                {
                    "first": "Jesus G.",
                    "initial": "J.G.",
                    "last": "Valenzuela"
                }
            ],
            "doi": "10.1126/scitranslmed.aaa3043",
            "issn": "19466234",
            "pmid": "26041707",
            "pub_year": 2015,
            "title": "A sand fly salivary protein vaccine shows efficacy against vector-transmitted cutaneous leishmaniasis in nonhuman primates",
            "volume": "7"
        },
        "b0190": {
            "authors": [
                {
                    "first": "Akinori",
                    "initial": "A.",
                    "last": "Takaoka"
                },
                {
                    "first": "Zhichao",
                    "initial": "Z.",
                    "last": "Wang"
                },
                {
                    "first": "Myoung Kwon",
                    "initial": "M.K.",
                    "last": "Choi"
                },
                {
                    "first": "Hideyuki",
                    "initial": "H.",
                    "last": "Yanai"
                },
                {
                    "first": "Hideo",
                    "initial": "H.",
                    "last": "Negishi"
                },
                {
                    "first": "Tatsuma",
                    "initial": "T.",
                    "last": "Ban"
                },
                {
                    "first": "Yan",
                    "initial": "Y.",
                    "last": "Lu"
                },
                {
                    "first": "Makoto",
                    "initial": "M.",
                    "last": "Miyagishi"
                },
                {
                    "first": "Tatsuhiko",
                    "initial": "T.",
                    "last": "Kodama"
                },
                {
                    "first": "Kenya",
                    "initial": "K.",
                    "last": "Honda"
                },
                {
                    "first": "Yusuke",
                    "initial": "Y.",
                    "last": "Ohba"
                },
                {
                    "first": "Tadatsugu",
                    "initial": "T.",
                    "last": "Taniguchi"
                }
            ],
            "doi": "10.1038/nature06013",
            "firstpage": "501",
            "issn": "00280836",
            "lastpage": "505",
            "pmid": "17618271",
            "pub_year": 2007,
            "title": "DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response",
            "volume": "448"
        },
        "b0195": {
            "authors": [
                {
                    "first": "Zhengrong",
                    "initial": "Z.",
                    "last": "Cui"
                },
                {
                    "first": "Su Ji",
                    "initial": "S.J.",
                    "last": "Han"
                },
                {
                    "first": "Dileep Padinjarae",
                    "initial": "D.P.",
                    "last": "Vangasseri"
                },
                {
                    "first": "Leaf",
                    "initial": "L.",
                    "last": "Huang"
                }
            ],
            "doi": "10.1021/mp049907k",
            "firstpage": "22",
            "issn": "15438384",
            "lastpage": "28",
            "pmid": "15804174",
            "pub_year": 2005,
            "title": "Immunostimulation mechanism of LPD nanoparticle as a vaccine carrier",
            "volume": "2"
        },
        "b0200": {
            "authors": [
                {
                    "first": "Zhengrong",
                    "initial": "Z.",
                    "last": "Cui"
                },
                {
                    "first": "Leaf",
                    "initial": "L.",
                    "last": "Huang"
                }
            ],
            "doi": "10.1007/s00262-005-0685-2",
            "firstpage": "1180",
            "issn": "03407004",
            "lastpage": "1190",
            "pmid": "15846491",
            "pub_year": 2005,
            "title": "Liposome-polycation-DNA (LPD) particle as a carrier and adjuvant for protein-based vaccines: Therapeutic effect against cervical cancer",
            "volume": "54"
        },
        "b0205": {
            "authors": [
                {
                    "first": "Lance W.",
                    "initial": "L.W.",
                    "last": "U'Ren"
                },
                {
                    "first": "Barbara J.",
                    "initial": "B.J.",
                    "last": "Biller"
                },
                {
                    "first": "Robyn E.",
                    "initial": "R.E.",
                    "last": "Elmslie"
                },
                {
                    "first": "Douglas H.",
                    "initial": "D.H.",
                    "last": "Thamm"
                },
                {
                    "first": "Steven W.",
                    "initial": "S.W.",
                    "last": "Dow"
                }
            ],
            "doi": "10.1892/0891-6640(2007)21[113:EOANTV]2.0.CO;2",
            "firstpage": "113",
            "issn": "08916640",
            "lastpage": "120",
            "pmid": "17338158",
            "pub_year": 2007,
            "title": "Evaluation of a novel tumor vaccine in dogs with hemangiosarcoma",
            "volume": "21"
        },
        "b0210": {
            "authors": [
                {
                    "first": "Mayda",
                    "initial": "M.",
                    "last": "G\u00fcrsel"
                },
                {
                    "first": "Sedef",
                    "initial": "S.",
                    "last": "Tunca"
                },
                {
                    "first": "Melek",
                    "initial": "M.",
                    "last": "\u00d6zkan"
                },
                {
                    "first": "G\u00fclay",
                    "initial": "G.",
                    "last": "\u00d6zcengiz"
                },
                {
                    "first": "G\u00fcrdal",
                    "initial": "G.",
                    "last": "Alaeddinoglu"
                }
            ],
            "doi": "10.1016/S0264-410X(98)00383-1",
            "firstpage": "1376",
            "issn": "0264410X",
            "lastpage": "1383",
            "pmid": "10195773",
            "pub_year": 1999,
            "title": "Immunoadjuvant action of plasmid DNA in liposomes",
            "volume": "17"
        },
        "b0215": {
            "authors": [
                {
                    "first": "Steven W.",
                    "initial": "S.W.",
                    "last": "Dow"
                }
            ],
            "doi": "10.1517/17425247.5.1.11",
            "firstpage": "11",
            "issn": "17425247",
            "lastpage": "24",
            "pmid": "18095926",
            "pub_year": 2008,
            "title": "Liposome-nucleic acid immunotherapeutics",
            "volume": "5"
        },
        "b0220": {
            "authors": [
                {
                    "first": "Nicolas",
                    "initial": "N.",
                    "last": "Collin"
                },
                {
                    "first": "Regis",
                    "initial": "R.",
                    "last": "Gomes"
                },
                {
                    "first": "Clarissa",
                    "initial": "C.",
                    "last": "Teixeira"
                },
                {
                    "first": "Lily",
                    "initial": "L.",
                    "last": "Cheng"
                },
                {
                    "first": "Andre",
                    "initial": "A.",
                    "last": "Laughinghouse"
                },
                {
                    "first": "Jerrold M.",
                    "initial": "J.M.",
                    "last": "Ward"
                },
                {
                    "first": "Dia Eldin",
                    "initial": "D.E.",
                    "last": "Elnaiem"
                },
                {
                    "first": "Laurent",
                    "initial": "L.",
                    "last": "Fischer"
                },
                {
                    "first": "Jesus G.",
                    "initial": "J.G.",
                    "last": "Valenzuela"
                },
                {
                    "first": "Shaden",
                    "initial": "S.",
                    "last": "Kamhawi"
                }
            ],
            "doi": "10.1371/journal.ppat.1000441",
            "issn": "15537366",
            "pmid": "19461875",
            "pub_year": 2009,
            "title": "Sand fly salivary proteins induce strong cellular immunity in a natural reservoir of visceral leishmaniasis with adverse consequences for Leishmania",
            "volume": "5"
        },
        "b0225": {
            "authors": [
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Inagaki"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Yoshida"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Mizuta"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Mizuno"
                },
                {
                    "first": "Y.",
                    "initial": "Y.",
                    "last": "Fujji"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Gonoi"
                },
                {
                    "first": "J. I.",
                    "initial": "J.I.",
                    "last": "Miyazaki -"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Seino"
                }
            ],
            "doi": "10.1073/pnas.91.7.2679",
            "firstpage": "2679",
            "issn": "00278424",
            "lastpage": "2683",
            "pmid": "8146174",
            "pub_year": 1994,
            "title": "Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin- secreting cells",
            "volume": "91"
        },
        "b0230": {
            "authors": [
                {
                    "first": "Vemuri B.",
                    "initial": "V.B.",
                    "last": "Reddy"
                },
                {
                    "first": "Yhong",
                    "initial": "Y.",
                    "last": "Li"
                },
                {
                    "first": "Ethan A.",
                    "initial": "E.A.",
                    "last": "Lerner"
                }
            ],
            "doi": "10.1007/s12031-008-9079-1",
            "firstpage": "241",
            "issn": "08958696",
            "lastpage": "244",
            "pmid": "18509762",
            "pub_year": 2008,
            "title": "Maxadilan, the PAC1 receptor, and leishmaniasis",
            "volume": "36"
        },
        "b0235": {
            "authors": [
                {
                    "first": "John Paul",
                    "initial": "J.P.",
                    "last": "Mutebi"
                },
                {
                    "first": "Bruce",
                    "initial": "B.",
                    "last": "Alexander"
                },
                {
                    "first": "Italo",
                    "initial": "I.",
                    "last": "Sherlock"
                },
                {
                    "first": "Jose",
                    "initial": "J.",
                    "last": "Wellington"
                },
                {
                    "first": "Adelson A.",
                    "initial": "A.A.",
                    "last": "Souza"
                },
                {
                    "first": "Jeffrey",
                    "initial": "J.",
                    "last": "Shaw"
                },
                {
                    "first": "Elizabeth F.",
                    "initial": "E.F.",
                    "last": "Rangel"
                },
                {
                    "first": "Gregory C.",
                    "initial": "G.C.",
                    "last": "Lanzaro"
                }
            ],
            "doi": "10.4269/ajtmh.1999.61.149",
            "firstpage": "149",
            "issn": "00029637",
            "lastpage": "157",
            "pmid": "10432072",
            "pub_year": 1999,
            "title": "Breeding structure of the sand fly Lutzomyia longipalpis (Lutz and Neiva) in Brazil",
            "volume": "61"
        }
    },
    "body_text": [
        {
            "endOffset": 35415,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "s0055",
            "sentence": "1 \u00d7 106 cells were added to each well of a 48-well plate in a volume of 500 \u00b5L of complete RPMI medium.",
            "startOffset": 35312,
            "title": "Isolation and stimulation of lymphocytes"
        },
        {
            "endOffset": 38082,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "BALB/c, C57BL/6 and C3H-HEN mice were vaccinated and boosted separately with 12 MAX-CLDC candidate vaccines (the Full-length (FL) MAX and 11 MAX peptide vaccine formulations) (n = 5 mice per vaccine candidate)).",
            "startOffset": 37871,
            "title": "Footpad lesions show comparative improvement in Lm+MAX-challenged mice vaccinated with CLDC containing peptides from FL MAX or 15 AA peptides from N- or C- terminal regions of MAX"
        },
        {
            "endOffset": 31311,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Animal maintenance and care complied with National Institutes of Health Guidelines (under pathogen-free conditions) for the humane use of laboratory animals and institutional policies as described in the American Association of Laboratory Animal Care and Institutional Guidelines.",
            "startOffset": 31031,
            "title": "Mice"
        },
        {
            "endOffset": 42086,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "In contrast, sera from mice vaccinated with CLDC deploying P3-4 and P6-10 failed to detect plate-bound MAX in ELISA assays whereas the P5 formulation yielded an antibody titer that had no efficacy (Data not shown, Fig. 2 and supplementary Fig. S3).",
            "startOffset": 41838,
            "title": "Serum antibodies from BALB/c, C57BL/6 and C3H immunized with the P11 CLDC recognize both FL MAX and the P11 peptide and neutralized MAX-mediated DC reprograming in vitro"
        },
        {
            "endOffset": 51381,
            "parents": [],
            "secId": "s0100",
            "sentence": "Thus development of \u201cregional\u201d vaccines may be necessary.",
            "startOffset": 51324,
            "title": "Discussion"
        },
        {
            "endOffset": 28742,
            "parents": [],
            "secId": "s0005",
            "sentence": "Since transmission/infection with Leishmania parasites is always in the context of saliva, conventional anti-leishmania vaccines that deploy merely parasite antigens (Ag) may have the potential to fail because they depend on non-subjugated host immune responses.",
            "startOffset": 28480,
            "title": "Introduction"
        },
        {
            "endOffset": 35083,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "s0055",
            "sentence": "One week following boost, mice were either unchallenged or challenged with Lm + MAX.",
            "startOffset": 34999,
            "title": "Isolation and stimulation of lymphocytes"
        },
        {
            "endOffset": 33599,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "s0045",
            "sentence": "MAX-CLDC vaccine candidates (FL-MAX or MAX peptides admixed with CLDC) were injected s.c. (two-50 \u00b5l injections) into the proximal base-of-tail regions.",
            "startOffset": 33447,
            "title": "Immunizing against MAX and Lm challenges"
        },
        {
            "endOffset": 31661,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "refoffsets": {
                "b0055": {
                    "endOffset": 31660,
                    "startOffset": 31653
                },
                "b0060": {
                    "endOffset": 31660,
                    "startOffset": 31653
                }
            },
            "secId": "s0025",
            "sentence": "Metacyclic promastigotes, from stationary phase promastigotes of Lm (LV39 (MRHO/Sv/59/P)) were purified using peanut agglutinin and used for all challenges as described previously [11,12].",
            "startOffset": 31473,
            "title": "Lm challenges"
        },
        {
            "endOffset": 42632,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "As controls, BM-DCs were pretreated with the type 1 pituitary adenylate cyclase-activating peptide (PAC1) receptor antagonist, PACAP6-38, prior to MAX treatment.",
            "startOffset": 42471,
            "title": "Serum antibodies from BALB/c, C57BL/6 and C3H immunized with the P11 CLDC recognize both FL MAX and the P11 peptide and neutralized MAX-mediated DC reprograming in vitro"
        },
        {
            "endOffset": 39787,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "Fig. 2a and 2b show that, in the Lm susceptible BALB/c strain and the healing C57BL/6 strain, parasite burden is apparent after 9 weeks post-challenge with either Lm or Lm + MAX while overall parasite burden is comparatively low in C3H mice (Fig. 2c).",
            "startOffset": 39536,
            "title": "Reduced parasite burden in footpads from peptide-vaccinated mice 9 and 18 weeks post low-dose Lm+MAX challenge"
        },
        {
            "endOffset": 47822,
            "parents": [],
            "secId": "s0100",
            "sentence": "MAX was deployed as Ag in this study because it is better biochemically characterized, and thus more suited to analysis.",
            "startOffset": 47702,
            "title": "Discussion"
        },
        {
            "endOffset": 27147,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 27146,
                    "startOffset": 27143
                }
            },
            "secId": "s0005",
            "sentence": "Vector-borne disease continues to pose significant global morbidity and mortality accounting for more than 17% of all infectious diseases causing more than 1 million deaths annually [1].",
            "startOffset": 26961,
            "title": "Introduction"
        },
        {
            "endOffset": 50235,
            "parents": [],
            "secId": "s0100",
            "sentence": "Among known natural MAX variants, the 15 AA (P11) C-terminal domain is somewhat conserved with only a few AA substitutions that are themselves conservative.",
            "startOffset": 50079,
            "title": "Discussion"
        },
        {
            "endOffset": 38863,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "Mice vaccinated with FL-MAX/CLDC were protected from lesion swelling (Supplementary Figs. S2 and S3).",
            "startOffset": 38762,
            "title": "Footpad lesions show comparative improvement in Lm+MAX-challenged mice vaccinated with CLDC containing peptides from FL MAX or 15 AA peptides from N- or C- terminal regions of MAX"
        },
        {
            "endOffset": 49279,
            "parents": [],
            "refoffsets": {
                "b0080": {
                    "endOffset": 49278,
                    "startOffset": 49268
                },
                "b0190": {
                    "endOffset": 49278,
                    "startOffset": 49268
                },
                "b0195": {
                    "endOffset": 49278,
                    "startOffset": 49268
                },
                "b0200": {
                    "endOffset": 49278,
                    "startOffset": 49268
                },
                "b0205": {
                    "endOffset": 49278,
                    "startOffset": 49268
                },
                "b0210": {
                    "endOffset": 49278,
                    "startOffset": 49268
                },
                "b0215": {
                    "endOffset": 49278,
                    "startOffset": 49268
                }
            },
            "secId": "s0100",
            "sentence": "When combined with nucleic acid agonists, the CLDC adjuvant offers immune potentiation and TLR ligands for endosomally located TLRs (TLR3, TLR7/8 and TLR9) and cytosolic nucleic acid receptors (e.g. RIG-I and DAI [16,38\u201343].",
            "startOffset": 49055,
            "title": "Discussion"
        },
        {
            "endOffset": 30602,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Antibodies used for flow cytometry were: FITC- and/or PE-conjugated anti-mouse CD11c, MHCII, CD86, CD3 and CD4, APC-conjugated anti-mouse CD8a (Ly-2), FITC-conjugated anti-mouse IFN-\u03b3 and FITC-conjugated anti-mouse IL-4 (eBioscience, San Diego, CA).",
            "startOffset": 30353,
            "title": "Reagents"
        },
        {
            "endOffset": 35707,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "s0055",
            "sentence": "Cells were processed according to manufacturer\u2019s protocol.",
            "startOffset": 35649,
            "title": "Isolation and stimulation of lymphocytes"
        },
        {
            "endOffset": 46557,
            "parents": [],
            "secId": "s0100",
            "sentence": "It is possible that the adjuvanted anti-MAX response primes host immunity to provoke Th1 responses necessary to resolve low-dose infection.",
            "startOffset": 46418,
            "title": "Discussion"
        },
        {
            "endOffset": 46703,
            "parents": [],
            "secId": "s0100",
            "sentence": "It is important to note that Lm is naturally transmitted by Old World sand flies such as P. papatasi and P. duboscqi not by the New World fly, Lu.",
            "startOffset": 46557,
            "title": "Discussion"
        },
        {
            "endOffset": 50292,
            "parents": [],
            "refoffsets": {
                "b0065": {
                    "endOffset": 50291,
                    "startOffset": 50287
                }
            },
            "secId": "s0100",
            "sentence": "Currently, there are only 4 known natural variants [13].",
            "startOffset": 50236,
            "title": "Discussion"
        },
        {
            "endOffset": 27624,
            "parents": [],
            "secId": "s0005",
            "sentence": "Such is the case for leishmaniasis.",
            "startOffset": 27589,
            "title": "Introduction"
        },
        {
            "endOffset": 33847,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "s0045",
            "sentence": "For adjuvant comparison experiments, mice were injected with 5\u201350 \u03bcg of synthetic MAX admixed with Alhydrogel\u00ae aluminum hydroxide gel adjuvant (Brenntag Biosector, Frederikssund, Denmark).",
            "startOffset": 33659,
            "title": "Immunizing against MAX and Lm challenges"
        },
        {
            "endOffset": 41379,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "Sera from FL-MAX-CLDC immunized mice contained antibodies that recognized primarily FL-MAX, P1, P2 and P11 MAX peptides as capture antigens (Data not shown).",
            "startOffset": 41222,
            "title": "Serum antibodies from BALB/c, C57BL/6 and C3H immunized with the P11 CLDC recognize both FL MAX and the P11 peptide and neutralized MAX-mediated DC reprograming in vitro"
        },
        {
            "endOffset": 46022,
            "parents": [],
            "secId": "s0100",
            "sentence": "These results also indicate the feasibility of generating a more affordable and easily manufactured anti-MAX vaccine by virtue of deploying small peptides.",
            "startOffset": 45867,
            "title": "Discussion"
        },
        {
            "endOffset": 50078,
            "parents": [],
            "secId": "s0100",
            "sentence": "While it is clear that variations of MAX exist, there are peptide domains that must remain conserved in order to fulfill requisite functions.",
            "startOffset": 49937,
            "title": "Discussion"
        },
        {
            "endOffset": 40839,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "This was not the case for the CLDC formulation (Supplemental Fig. S4).",
            "startOffset": 40769,
            "title": "Reduced parasite burden in footpads from peptide-vaccinated mice 9 and 18 weeks post low-dose Lm+MAX challenge"
        },
        {
            "endOffset": 49628,
            "parents": [],
            "secId": "s0100",
            "sentence": "In nature, Leishmania species are antigenically diverse confounding efforts to producing a single vaccine for disease control.",
            "startOffset": 49502,
            "title": "Discussion"
        },
        {
            "endOffset": 45392,
            "parents": [],
            "refoffsets": {
                "b0100": {
                    "endOffset": 45391,
                    "startOffset": 45384
                },
                "b0105": {
                    "endOffset": 45391,
                    "startOffset": 45384
                }
            },
            "secId": "s0100",
            "sentence": "The C- and N-terminal portions of MAX, have been shown to be important for either receptor binding or functionality [20,21].",
            "startOffset": 45268,
            "title": "Discussion"
        },
        {
            "endOffset": 41642,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "This was the case for all P11-CLDC vaccinated mice (not shown).",
            "startOffset": 41579,
            "title": "Serum antibodies from BALB/c, C57BL/6 and C3H immunized with the P11 CLDC recognize both FL MAX and the P11 peptide and neutralized MAX-mediated DC reprograming in vitro"
        },
        {
            "endOffset": 38761,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "Sham vaccination with CLDC alone in some cases prevented maximal swelling of footpad size; however there was no corresponding decrease in parasite burden in these mice (compare Fig. 1 panel B, (dot-dash line solid squares) with Fig. 2).",
            "startOffset": 38525,
            "title": "Footpad lesions show comparative improvement in Lm+MAX-challenged mice vaccinated with CLDC containing peptides from FL MAX or 15 AA peptides from N- or C- terminal regions of MAX"
        },
        {
            "endOffset": 39203,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "MAX + Lm challenged-mice using CLDC vaccines containing P3-P10 formulations did not demonstrate significant differences in footpad swelling when compared to those that were unvaccinated for all 3 strains of mice (Fig. S3 (for peptide P5) and data not shown).",
            "startOffset": 38945,
            "title": "Footpad lesions show comparative improvement in Lm+MAX-challenged mice vaccinated with CLDC containing peptides from FL MAX or 15 AA peptides from N- or C- terminal regions of MAX"
        },
        {
            "endOffset": 45523,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 45522,
                    "startOffset": 45513
                },
                "b0110": {
                    "endOffset": 45522,
                    "startOffset": 45513
                },
                "b0115": {
                    "endOffset": 45522,
                    "startOffset": 45513
                },
                "b0120": {
                    "endOffset": 45522,
                    "startOffset": 45513
                }
            },
            "secId": "s0100",
            "sentence": "MAX may skew dermal DCs and macrophages towards Type 2 immune responses rendering hosts more vulnerable to Lm infection [4,22\u201324].",
            "startOffset": 45393,
            "title": "Discussion"
        },
        {
            "endOffset": 40115,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "At 9 weeks post-challenge, when compared to challenge with Lm alone, MAX + Lm challenges resulted in averages of 10-fold, 5-fold, and 3-fold increases in parasite burden in BALB/c, C57 and C3H mice, respectively.",
            "startOffset": 39903,
            "title": "Reduced parasite burden in footpads from peptide-vaccinated mice 9 and 18 weeks post low-dose Lm+MAX challenge"
        },
        {
            "endOffset": 41221,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "Sera from mice vaccinated with CLDC and FL MAX- or C or N-terminal MAX peptides contained detectable titers of anti-MAX immunoglobulin at 18 weeks following immunization (Fig. 3A for Balb/c and data not shown).",
            "startOffset": 41011,
            "title": "Serum antibodies from BALB/c, C57BL/6 and C3H immunized with the P11 CLDC recognize both FL MAX and the P11 peptide and neutralized MAX-mediated DC reprograming in vitro"
        },
        {
            "endOffset": 48607,
            "parents": [],
            "secId": "s0100",
            "sentence": "Since no Lm Ags were used in the vaccine formulations, the platform described herein is not entirely prophylactic and Lm infection is initially established in all three strains of mice.",
            "startOffset": 48422,
            "title": "Discussion"
        },
        {
            "endOffset": 32732,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "refoffsets": {
                "b0075": {
                    "endOffset": 32730,
                    "startOffset": 32726
                }
            },
            "secId": "s0040",
            "sentence": "Cationic liposomes were prepared as previously described by combining equimolar amounts of DOTIM [octadecanoyloxy(ethyl-2-heptadecenyl-3-hydroxyethyl) imidazolinium chloride] and cholesterol [15]).",
            "startOffset": 32535,
            "title": "Preparation of CLDC and alhydrogel\u00ae adjuvants and combination with MAX Ags"
        },
        {
            "endOffset": 37471,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "s0070",
            "sentence": "Data were considered statistically significant for p < .05.",
            "startOffset": 37412,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 27433,
            "parents": [],
            "secId": "s0005",
            "sentence": "Many of these diseases continue to re-emerge in former endemic areas and/or emerge in new parts of the world where conventional means of control are often inadequate due to the emergence of pesticide-resistant vectors, drug-resistant pathogens, and collapse of vector control programs.",
            "startOffset": 27148,
            "title": "Introduction"
        },
        {
            "endOffset": 50831,
            "parents": [],
            "refoffsets": {
                "b0225": {
                    "endOffset": 50830,
                    "startOffset": 50823
                },
                "b0230": {
                    "endOffset": 50830,
                    "startOffset": 50823
                }
            },
            "secId": "s0100",
            "sentence": "The human ligand for PAC1, PACAP, is a neuropeptide and is involved in neurotransmission, vasodilation and various endocrine effects [45,46].",
            "startOffset": 50690,
            "title": "Discussion"
        },
        {
            "endOffset": 29687,
            "parents": [],
            "refoffsets": {
                "b0050": {
                    "endOffset": 29686,
                    "startOffset": 29682
                }
            },
            "secId": "s0005",
            "sentence": "longipalpis, MAX may be the major exacerbative element since vaccinating against this molecule neutralized the effects of whole saliva [10].",
            "startOffset": 29547,
            "title": "Introduction"
        },
        {
            "endOffset": 47333,
            "parents": [],
            "refoffsets": {
                "b0160": {
                    "endOffset": 47332,
                    "startOffset": 47328
                }
            },
            "secId": "s0100",
            "sentence": "longipalpis and L. amazonensis [32].",
            "startOffset": 47297,
            "title": "Discussion"
        },
        {
            "endOffset": 46716,
            "parents": [],
            "secId": "s0100",
            "sentence": "longipalpis.",
            "startOffset": 46704,
            "title": "Discussion"
        },
        {
            "endOffset": 41578,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "Serum ELISA from P11-CLDC-immunized Balb/c mice indicated that antibodies are elicited in response to this vaccine and are restricted to recognition of the FL-MAX and P11 epitopes (Fig. 3; panel B).",
            "startOffset": 41380,
            "title": "Serum antibodies from BALB/c, C57BL/6 and C3H immunized with the P11 CLDC recognize both FL MAX and the P11 peptide and neutralized MAX-mediated DC reprograming in vitro"
        },
        {
            "endOffset": 48231,
            "parents": [],
            "refoffsets": {
                "b0175": {
                    "endOffset": 48230,
                    "startOffset": 48223
                },
                "b0180": {
                    "endOffset": 48230,
                    "startOffset": 48223
                }
            },
            "secId": "s0100",
            "sentence": "It has been postulated that antibodies play no role in saliva-mediated protection [35,36].",
            "startOffset": 48141,
            "title": "Discussion"
        },
        {
            "endOffset": 48057,
            "parents": [],
            "secId": "s0100",
            "sentence": "In the current study, the overall percentage ratio of IFN\u03b3- vs. IL-4-producing CD4+ cells in the draining LN of MAX-CLDC-immunized mice was 2.53, in comparison to a ratio of 1.13 in non-immunized mice, suggesting an increased Th1-bias.",
            "startOffset": 47822,
            "title": "Discussion"
        },
        {
            "endOffset": 36729,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "s0065",
            "sentence": "Following 5\u20137 days in GM\u2212CSF/IL-4 culture, cells were harvested and CD11c+ cells were purified using the magnetic bead isolation kit from Miltenyi Biotec (San Diego, CA).",
            "startOffset": 36559,
            "title": "Isolation of DCs from in vitro cultures of bone marrow cells"
        },
        {
            "endOffset": 36403,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "s0060",
            "sentence": "Intracellular cytokines (IFN\u03b3 or IL-4) were stained using FITC-conjugated antibodies and analyzed for expression of cytokines by flow cytometry, (CyAn flow cytometer, DakoCytomation, Fort Collins, Colorado) using Summit Acquisition Software, Version 4.2.",
            "startOffset": 36149,
            "title": "Intracellular cytokine staining and flow cytometry"
        },
        {
            "endOffset": 39535,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "In all challenged/unvaccinated mice parasite burden was initially high.",
            "startOffset": 39464,
            "title": "Reduced parasite burden in footpads from peptide-vaccinated mice 9 and 18 weeks post low-dose Lm+MAX challenge"
        },
        {
            "endOffset": 45639,
            "parents": [],
            "secId": "s0100",
            "sentence": "The low-dose challenges increased the time for the development of relatively minor lesions in C3H and C57BL/6 mice.",
            "startOffset": 45524,
            "title": "Discussion"
        },
        {
            "endOffset": 51005,
            "parents": [],
            "refoffsets": {
                "b0105": {
                    "endOffset": 51004,
                    "startOffset": 51000
                }
            },
            "secId": "s0100",
            "sentence": "PACAP has no structural or sequence similarity to MAX so antibodies generated against MAX likely won\u2019t cross-react with PACAP and negatively affect its binding to PAC1 [21].",
            "startOffset": 50832,
            "title": "Discussion"
        },
        {
            "endOffset": 51198,
            "parents": [],
            "secId": "s0100",
            "sentence": "As a rule, sand flies are not strong fliers and, as such, local populations of Lu.",
            "startOffset": 51116,
            "title": "Discussion"
        },
        {
            "endOffset": 31932,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "refoffsets": {
                "b0065": {
                    "endOffset": 31931,
                    "startOffset": 31927
                }
            },
            "secId": "s0030",
            "sentence": "The 63 amino acid sequence used was based on the sequence of mature, secreted MAX [13].",
            "startOffset": 31845,
            "title": "Synthetic maxadilan and MAX peptides"
        },
        {
            "endOffset": 31030,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Mice were maintained at the Laboratory Animal Resources facility at CSU, Fort Collins, CO.",
            "startOffset": 30940,
            "title": "Mice"
        },
        {
            "endOffset": 33658,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Two weeks later, the mice were boosted in the same manner.",
            "startOffset": 33600,
            "title": "Immunizing against MAX and Lm challenges"
        },
        {
            "endOffset": 37810,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "MAX-CLDC vaccine candidate antigens were comprised of either synthetic full-length (FL) MAX or short 15 AA peptides spanning the 63 AA length of MAX.",
            "startOffset": 37661,
            "title": "Footpad lesions show comparative improvement in Lm+MAX-challenged mice vaccinated with CLDC containing peptides from FL MAX or 15 AA peptides from N- or C- terminal regions of MAX"
        },
        {
            "endOffset": 35311,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "s0055",
            "sentence": "One week later (4 weeks after initial vaccination) the popliteal and/or paraaortic/lumbar lymph nodes (LN) were harvested (n = 5\u20138) and mechanically disrupted to prepare separate single-cell suspensions in complete RPMI medium.",
            "startOffset": 35084,
            "title": "Isolation and stimulation of lymphocytes"
        },
        {
            "endOffset": 49769,
            "parents": [],
            "secId": "s0100",
            "sentence": "Additionally, development of a universal anti-MAX vaccine has been hampered by concerns that considerable variation of MAX exists in nature.",
            "startOffset": 49629,
            "title": "Discussion"
        },
        {
            "endOffset": 28103,
            "parents": [],
            "refoffsets": {
                "b0010": {
                    "endOffset": 28102,
                    "startOffset": 28097
                },
                "b0015": {
                    "endOffset": 28102,
                    "startOffset": 28097
                }
            },
            "secId": "s0005",
            "sentence": "The saliva of blood-feeding insects has abundance of pharmacologically active components that serve individually or collectively to usurp the host hemostatic system likely evolved to optimize the acquisition of a blood meal and fecundity [2,3].",
            "startOffset": 27859,
            "title": "Introduction"
        },
        {
            "endOffset": 30811,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The pituitary adenylate cyclase-activating peptide (PACAP) receptor antagonist PACAP-(6-38) was obtained from Bachem (Heidelberg, Germany).",
            "startOffset": 30672,
            "title": "Reagents"
        },
        {
            "endOffset": 44711,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0095",
            "sentence": "Whereas ratio of IFN\u03b3- vs. IL-4-producting CD4+ cells was only 1.13 in non-immunized animals, suggesting an increased Th1-bias in all strains due to immunization with CLDC+MAX.",
            "startOffset": 44535,
            "title": "MAX-CLDC immunized mice challenged with Lm + MAX have increased percentages of IFN\u03b3-secreting and decreased IL-4-secreting CD4+ cells from footpad draining lymph nodes (LNs)"
        },
        {
            "endOffset": 48422,
            "parents": [],
            "secId": "s0100",
            "sentence": "We hypothesize otherwise that anti-MAX Abs may serve to neutralize the potentiation effect of MAX thereby establishing transmission of the parasite in a more protective Th1 microenvironment.",
            "startOffset": 48232,
            "title": "Discussion"
        },
        {
            "endOffset": 32310,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Lesion development was followed by measuring increased thickness of infected footpads with a Vernier\u00ae caliper and comparisons made between the footpads of the contralateral and of unchallenged controls (Supplemental Fig. S2).",
            "startOffset": 32085,
            "title": "Monitoring lesion development and parasite burden in footpads"
        },
        {
            "endOffset": 37411,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "s0070",
            "sentence": "For comparisons between two groups, two-tailed t tests were performed.",
            "startOffset": 37341,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 34898,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Plates were read on a Bio-Rad model 2550 plate reader (Bio-Rad, Hercules, CA).",
            "startOffset": 34820,
            "title": "Anti-MAX ELISA"
        },
        {
            "endOffset": 44195,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0095",
            "sentence": "Similar analysis of IL-4-producing cells demonstrated a decrease from 2.7% to 1.84% representing an approximate 45% decrease in IL-4-producing CD4+ cells in response to Lm + MAX challenge (Fig. 5; panel A).",
            "startOffset": 43989,
            "title": "MAX-CLDC immunized mice challenged with Lm + MAX have increased percentages of IFN\u03b3-secreting and decreased IL-4-secreting CD4+ cells from footpad draining lymph nodes (LNs)"
        },
        {
            "endOffset": 42470,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "In addition, sera from MAX-P11-CLDC vaccinated mice blocked the MAX-mediated up-regulation of CD86 on LPS-stimulated BM-DCs.",
            "startOffset": 42346,
            "title": "Serum antibodies from BALB/c, C57BL/6 and C3H immunized with the P11 CLDC recognize both FL MAX and the P11 peptide and neutralized MAX-mediated DC reprograming in vitro"
        },
        {
            "endOffset": 47296,
            "parents": [],
            "refoffsets": {
                "b0155": {
                    "endOffset": 47287,
                    "startOffset": 47283
                }
            },
            "secId": "s0100",
            "sentence": "longipalpis and Leishmania donovani chagasi [31], and Lu.",
            "startOffset": 47239,
            "title": "Discussion"
        },
        {
            "endOffset": 38417,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "P1-, P2- and P11-CLDC vaccines were efficacious in terms of reduced lesion size.",
            "startOffset": 38337,
            "title": "Footpad lesions show comparative improvement in Lm+MAX-challenged mice vaccinated with CLDC containing peptides from FL MAX or 15 AA peptides from N- or C- terminal regions of MAX"
        },
        {
            "endOffset": 34998,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "s0055",
            "sentence": "Mice were vaccinated followed by a boost two weeks later.",
            "startOffset": 34941,
            "title": "Isolation and stimulation of lymphocytes"
        },
        {
            "endOffset": 36148,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "s0060",
            "sentence": "Cells were permeabilized, stained and fixed using Cytofix/Cytoperm\u2122(BD Biosciences San Diego, CA) according to manufacturer\u2019s protocols.",
            "startOffset": 36012,
            "title": "Intracellular cytokine staining and flow cytometry"
        },
        {
            "endOffset": 46167,
            "parents": [],
            "secId": "s0100",
            "sentence": "Significantly, very few or no parasites were detected in MAX-CLDC or P1, P2 and P11-CLDC vaccinated BALB/c mice footpads 18 weeks post-challenge.",
            "startOffset": 46022,
            "title": "Discussion"
        },
        {
            "endOffset": 50461,
            "parents": [],
            "refoffsets": {
                "b0105": {
                    "endOffset": 50460,
                    "startOffset": 50456
                }
            },
            "secId": "s0100",
            "sentence": "This conservation has been demonstrated by the construction of MAX deletion mutants showing that the C-terminal domain is absolutely required for receptor binding [21].",
            "startOffset": 50293,
            "title": "Discussion"
        },
        {
            "endOffset": 43138,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "As a control for the PACAP6-38 treatment, DC pretreated with ovalabumin258-265 peptide, SIINFEKL, did not affect the LPS + MAX response on BM-DCs (Fig. 4).",
            "startOffset": 42983,
            "title": "Serum antibodies from BALB/c, C57BL/6 and C3H immunized with the P11 CLDC recognize both FL MAX and the P11 peptide and neutralized MAX-mediated DC reprograming in vitro"
        },
        {
            "endOffset": 46915,
            "parents": [],
            "secId": "s0100",
            "sentence": "Hence this study does not use a salivary component from natural vectors for Lm and thus not strictly mimicking the natural infective process by pairing the appropriate sand fly/parasite combination.",
            "startOffset": 46717,
            "title": "Discussion"
        },
        {
            "endOffset": 37115,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "s0065",
            "sentence": "Bone marrow-derived- (BM)-DCs were treated with either vehicle (PBS), 10 ng/ml MAX, 10 ng/ml MAX pretreated with 1% anti-MAX antisera, 7 ng/ml PACAP6-38 (PAC1 antagonist) or 5 ng/ml OVA258-265 SIINFEKL for 3 h. DCs were subsequently treated with 500 ng/ml lipopolysaccharide (LPS) for 36 h and expression of CD80 and CD86 were determined by flow cytometric analysis as described above.",
            "startOffset": 36730,
            "title": "Isolation of DCs from in vitro cultures of bone marrow cells"
        },
        {
            "endOffset": 35648,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "s0055",
            "sentence": "1 \u00b5L of both Cell Stimulation Cocktail (500x, eBioscience, San Diego, CA) and GolgiPlug\u2122 Protein Transport Inhibitor (BD Biosciences Pharmingen, San Diego, CA) were added to each well, and cells were then incubated for 5 h at 37 \u00b0C.",
            "startOffset": 35416,
            "title": "Isolation and stimulation of lymphocytes"
        },
        {
            "endOffset": 36011,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "s0060",
            "sentence": "Following stimulation, cells were suspended in FACS staining buffer (PBS, 0.5% BSA, and 0.01% azide) and treated for 15 min with Fc receptor block (Miltenyi Biotec, San Diego, CA) and surface-labeled with PE- or APC-conjugated Abs for 20 min at 4 \u00b0C.",
            "startOffset": 35761,
            "title": "Intracellular cytokine staining and flow cytometry"
        },
        {
            "endOffset": 29490,
            "parents": [],
            "secId": "s0005",
            "sentence": "In the past, we have shown that injection of Leishmania major (Lm) admixed with the Lutzomyia longipalpis sand fly salivary peptide maxadilan (MAX), can substitute for whole saliva exacerbating infections in terms of induration of lesion and parasite burden while vaccination against MAX is protective against infection with Lm in the context of vector saliva.",
            "startOffset": 29130,
            "title": "Introduction"
        },
        {
            "endOffset": 43583,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0095",
            "sentence": "One week post-challenge with Lm + MAX, footpad-draining (popliteal (or paraaortic/lumbar)) LNs were harvested from mice (n = 3\u20135 animals) that were previously unvaccinated (control), or immunized with either FL-MAX-CLDC or CLDC admixed with hen egg lysozyme (HEL-CLDC).",
            "startOffset": 43314,
            "title": "MAX-CLDC immunized mice challenged with Lm + MAX have increased percentages of IFN\u03b3-secreting and decreased IL-4-secreting CD4+ cells from footpad draining lymph nodes (LNs)"
        },
        {
            "endOffset": 43988,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0095",
            "sentence": "Flow cytometric analysis of CD3/CD4++ events revealed an increased percentage of IFN\u03b3-producing cells in LN from MAX-CLDC immunized animals from 3.1% to 5.11% representing an approximate 65% overall increase in IFN\u03b3-producing cells (Fig. 5; Panel A).",
            "startOffset": 43738,
            "title": "MAX-CLDC immunized mice challenged with Lm + MAX have increased percentages of IFN\u03b3-secreting and decreased IL-4-secreting CD4+ cells from footpad draining lymph nodes (LNs)"
        },
        {
            "endOffset": 51115,
            "parents": [],
            "secId": "s0100",
            "sentence": "Longipalpis.",
            "startOffset": 51103,
            "title": "Discussion"
        },
        {
            "endOffset": 47701,
            "parents": [],
            "refoffsets": {
                "b0010": {
                    "endOffset": 47700,
                    "startOffset": 47691
                },
                "b0165": {
                    "endOffset": 47700,
                    "startOffset": 47691
                },
                "b0170": {
                    "endOffset": 47700,
                    "startOffset": 47691
                }
            },
            "secId": "s0100",
            "sentence": "Although MAX is absent from P. papatasi saliva, activities such as vasodilation and immune modulation that are related to MAX have been attributed to a variety of Old Word sand fly salivary molecules [2,33,34].",
            "startOffset": 47491,
            "title": "Discussion"
        },
        {
            "endOffset": 49055,
            "parents": [],
            "refoffsets": {
                "b0185": {
                    "endOffset": 49054,
                    "startOffset": 49050
                }
            },
            "secId": "s0100",
            "sentence": "Combinatorial vaccines that incorporate antigens of various Leishmania spp. as well as their cognate salivary potentiators would likely provide the best components for an eventual efficacious prophylactic vaccine [37].",
            "startOffset": 48837,
            "title": "Discussion"
        },
        {
            "endOffset": 34136,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Fourteen days later, the mice were boosted in an identical fashion.",
            "startOffset": 34069,
            "title": "Immunizing against MAX and Lm challenges"
        },
        {
            "endOffset": 34390,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Blood was collected from tail bleeds at 18 weeks following Lm challenge, and the anti-MAX serum titer was determined by ELISA.",
            "startOffset": 34264,
            "title": "Anti-MAX ELISA"
        },
        {
            "endOffset": 37870,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "Synthetic peptides are illustrated in Supplemental Fig. S1.",
            "startOffset": 37811,
            "title": "Footpad lesions show comparative improvement in Lm+MAX-challenged mice vaccinated with CLDC containing peptides from FL MAX or 15 AA peptides from N- or C- terminal regions of MAX"
        },
        {
            "endOffset": 48836,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 48835,
                    "startOffset": 48830
                },
                "b0025": {
                    "endOffset": 48835,
                    "startOffset": 48830
                }
            },
            "secId": "s0100",
            "sentence": "Rather, the established immunity to this salivary component may prevent the reprograming of innate immune responses permitting a more protective host cellular response against parasite transmission, growth and persistence [4,5].",
            "startOffset": 48608,
            "title": "Discussion"
        },
        {
            "endOffset": 46417,
            "parents": [],
            "secId": "s0100",
            "sentence": "This poses a conundrum since BALB/c mice are susceptible to Lm regardless of whether vectored by sand flies or co-injected with either salivary gland extract (SGE) or MAX.",
            "startOffset": 46246,
            "title": "Discussion"
        },
        {
            "endOffset": 34819,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "refoffsets": {
                "b0085": {
                    "endOffset": 34517,
                    "startOffset": 34510
                },
                "b0090": {
                    "endOffset": 34517,
                    "startOffset": 34510
                }
            },
            "secId": "s0050",
            "sentence": "Briefly, ELISA plates were coated with synthetic FL MAX (10 \u03bcg/ml) or MAX peptides (2 \u03bcg/ml) using standard techniques [17,18]) and developed with horseradish peroxidase (HRP)-conjugated goat anti-mouse Ig that detects Ig classes/isotypes (IgG, IgM, IgA polyvalent) (Sigma Aldrich, St. Louis, MO), and developed using the 3,3\u2032,5,5\u2032-Tetramethylbenzidine (TMB) substrate reagent (Becton Dickinson Biosciences, Franklin Lakes, NJ).",
            "startOffset": 34391,
            "title": "Anti-MAX ELISA"
        },
        {
            "endOffset": 37340,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "s0070",
            "sentence": "Data for lesion progression were analyzed using ANOVA for repeated measure with Tukey\u2019s multiple comparisons test.",
            "startOffset": 37226,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 38944,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "However, those vaccinated with FL-MAX alone were not protected (Data not shown.)",
            "startOffset": 38864,
            "title": "Footpad lesions show comparative improvement in Lm+MAX-challenged mice vaccinated with CLDC containing peptides from FL MAX or 15 AA peptides from N- or C- terminal regions of MAX"
        },
        {
            "endOffset": 27588,
            "parents": [],
            "secId": "s0005",
            "sentence": "At present, safe and effective vaccines and therapeutics for prevention and treatment for many of these conditions are inadequate or all together lacking.",
            "startOffset": 27434,
            "title": "Introduction"
        },
        {
            "endOffset": 50689,
            "parents": [],
            "refoffsets": {
                "b0225": {
                    "endOffset": 50688,
                    "startOffset": 50684
                }
            },
            "secId": "s0100",
            "sentence": "The PAC1 receptor for MAX is expressed on a variety of cell types including, neurons, endothelial cells, macrophages, and DC [45].",
            "startOffset": 50559,
            "title": "Discussion"
        },
        {
            "endOffset": 29129,
            "parents": [],
            "refoffsets": {
                "b0030": {
                    "endOffset": 29128,
                    "startOffset": 29123
                },
                "b0035": {
                    "endOffset": 29128,
                    "startOffset": 29123
                },
                "b0040": {
                    "endOffset": 29128,
                    "startOffset": 29123
                },
                "b0045": {
                    "endOffset": 29128,
                    "startOffset": 29123
                }
            },
            "secId": "s0005",
            "sentence": "A crucial argument for the development of a saliva-based vaccine for leishmaniasis is the fact that prior exposure to uninfected sand fly bites and/or vaccination with various immunogenic components of sand fly saliva has been shown to confer protection from Leishmaniasis and that the majority of those who recover from the disease have lasting immunity against salivary proteins [6\u20139].",
            "startOffset": 28742,
            "title": "Introduction"
        },
        {
            "endOffset": 38524,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "The P11-CLDC vaccine consistently prevented the formation of severe footpad lesions throughout the course.",
            "startOffset": 38418,
            "title": "Footpad lesions show comparative improvement in Lm+MAX-challenged mice vaccinated with CLDC containing peptides from FL MAX or 15 AA peptides from N- or C- terminal regions of MAX"
        },
        {
            "endOffset": 51323,
            "parents": [],
            "refoffsets": {
                "b0235": {
                    "endOffset": 51322,
                    "startOffset": 51318
                }
            },
            "secId": "s0100",
            "sentence": "Longipalpis which have large geographical distributions throughout the New World are likely to be genetically isolated [47].",
            "startOffset": 51199,
            "title": "Discussion"
        },
        {
            "endOffset": 32458,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "refoffsets": {
                "b0070": {
                    "endOffset": 32457,
                    "startOffset": 32453
                }
            },
            "secId": "s0035",
            "sentence": "Parasite numbers in infected footpads were determined using a technically reliable published limiting dilution assay for Lm infection in mice [14].",
            "startOffset": 32311,
            "title": "Monitoring lesion development and parasite burden in footpads"
        },
        {
            "endOffset": 47075,
            "parents": [],
            "secId": "s0100",
            "sentence": "longipalpis.",
            "startOffset": 47063,
            "title": "Discussion"
        },
        {
            "endOffset": 27859,
            "parents": [],
            "secId": "s0005",
            "sentence": "The leishmaniases are a group of zoonotic vector-borne diseases caused by infection with obligate intracellular protozoa of the genus Leishmania, transmitted by infected female sand fly vectors of the genera Phlebotomus and Lutzomyia.",
            "startOffset": 27625,
            "title": "Introduction"
        },
        {
            "endOffset": 42982,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "MAX has been shown to interact and signal through PAC1 and likely mediates its immunosuppressive and anti-inflammatory effects thereof.",
            "startOffset": 42847,
            "title": "Serum antibodies from BALB/c, C57BL/6 and C3H immunized with the P11 CLDC recognize both FL MAX and the P11 peptide and neutralized MAX-mediated DC reprograming in vitro"
        },
        {
            "endOffset": 30671,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Fc receptor block was purchased from Miltenyi Biotec, San Diego, CA.",
            "startOffset": 30603,
            "title": "Reagents"
        },
        {
            "endOffset": 40768,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "Although FL-MAX-Alum proved to be efficacious, there was considerable inflammation at the injection site that persisted for over 240 days post-injection.",
            "startOffset": 40615,
            "title": "Reduced parasite burden in footpads from peptide-vaccinated mice 9 and 18 weeks post low-dose Lm+MAX challenge"
        },
        {
            "endOffset": 48140,
            "parents": [],
            "secId": "s0100",
            "sentence": "The increased amount of IFN\u03b3-secreting cells likely contributes to the protection.",
            "startOffset": 48058,
            "title": "Discussion"
        },
        {
            "endOffset": 45866,
            "parents": [],
            "refoffsets": {
                "b0125": {
                    "endOffset": 45865,
                    "startOffset": 45858
                },
                "b0130": {
                    "endOffset": 45865,
                    "startOffset": 45858
                },
                "b0135": {
                    "endOffset": 45865,
                    "startOffset": 45858
                }
            },
            "secId": "s0100",
            "sentence": "Parasite inoculums were at sand fly-carrying levels reported to be about 10\u20131000 parasites per inoculum [25\u201327].",
            "startOffset": 45754,
            "title": "Discussion"
        },
        {
            "endOffset": 39463,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "At 9 weeks and 18 weeks post Lm + MAX challenge, mice were euthanized and footpads were removed and the number of parasites/footpad was determined.",
            "startOffset": 39316,
            "title": "Reduced parasite burden in footpads from peptide-vaccinated mice 9 and 18 weeks post low-dose Lm+MAX challenge"
        },
        {
            "endOffset": 37225,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "s0070",
            "sentence": "Statistical analyses were conducted using Prism 7.0 software (GraphPad, La Jolla, CA).",
            "startOffset": 37139,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 47062,
            "parents": [],
            "secId": "s0100",
            "sentence": "Rather, we demonstrate the feasibility of generating a protective host immune response against MAX, a potent disease exacerbative component of Lu.",
            "startOffset": 46916,
            "title": "Discussion"
        },
        {
            "endOffset": 45013,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0095",
            "sentence": "The Th1-biased immune response is potentially capable of protecting against intracellular Lm infection; thus, the pattern of cytokine production identified in the draining lymph nodes of MAX-immunized mice challenged with Lm + MAX might, in part, account, for the protection induced against challenge.",
            "startOffset": 44712,
            "title": "MAX-CLDC immunized mice challenged with Lm + MAX have increased percentages of IFN\u03b3-secreting and decreased IL-4-secreting CD4+ cells from footpad draining lymph nodes (LNs)"
        },
        {
            "endOffset": 49502,
            "parents": [],
            "secId": "s0100",
            "sentence": "Indeed, in the current study, we demonstrate that CLDC-adjuvanted MAX performed better than alum in terms of lesion induration, parasite burden and inflammation at the injection site (Fig. 2, Supplemental Figs. S3 and S4).",
            "startOffset": 49280,
            "title": "Discussion"
        },
        {
            "endOffset": 49936,
            "parents": [],
            "refoffsets": {
                "b0220": {
                    "endOffset": 49935,
                    "startOffset": 49931
                }
            },
            "secId": "s0100",
            "sentence": "Variation has been speculated as being one of the adaptive mechanisms that sand flies have evolved to survive host immune responses generated by repeated biting [44].",
            "startOffset": 49770,
            "title": "Discussion"
        },
        {
            "endOffset": 51547,
            "parents": [],
            "secId": "s0100",
            "sentence": "Hence, in developing such vaccines, perhaps entertaining the notion of tailored vaccines enhanced by salivary components of regionally-specific vectors is warranted.",
            "startOffset": 51382,
            "title": "Discussion"
        },
        {
            "endOffset": 28479,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 28478,
                    "startOffset": 28473
                },
                "b0025": {
                    "endOffset": 28478,
                    "startOffset": 28473
                }
            },
            "secId": "s0005",
            "sentence": "In addition to their critical function of aiding sand fly feeding via various hemostatic effects, salivary components such as the vasodilator maxadilan (MAX) from Lutzomyia longipalpis have profound immunosuppressive and anti-inflammatory effects, properties that have been attributed to permitting parasite entry into hosts by localized commandeering of host immunity [4,5].",
            "startOffset": 28104,
            "title": "Introduction"
        },
        {
            "endOffset": 41837,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "These results in combination with lesion analysis and the parasite burden data suggest that the antibodies recognizing the P1, P2 and P11 regions of MAX likely contribute to a protective effect.",
            "startOffset": 41643,
            "title": "Serum antibodies from BALB/c, C57BL/6 and C3H immunized with the P11 CLDC recognize both FL MAX and the P11 peptide and neutralized MAX-mediated DC reprograming in vitro"
        },
        {
            "endOffset": 51102,
            "parents": [],
            "secId": "s0100",
            "sentence": "Indeed antibodies to MAX exist in the serum of dogs and people endemic to areas populated by Lu.",
            "startOffset": 51006,
            "title": "Discussion"
        },
        {
            "endOffset": 43737,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0095",
            "sentence": "Single cell suspensions were stimulated in vitro as described above, surface stained for CD3 and CD4 followed by intracellular staining for IFN\u03b3 or IL-4.",
            "startOffset": 43584,
            "title": "MAX-CLDC immunized mice challenged with Lm + MAX have increased percentages of IFN\u03b3-secreting and decreased IL-4-secreting CD4+ cells from footpad draining lymph nodes (LNs)"
        },
        {
            "endOffset": 30125,
            "parents": [],
            "secId": "s0005",
            "sentence": "The work described herein demonstrates that the synthetic full length (FL) MAX molecule as well as C and N terminal peptides derived thereof can be utilized successfully as antigens in a cationic lipid DNA complex (CLDC) adjuvant vaccine system protecting three strains of mice (representing murine susceptibility models ranging from extremely susceptible to completely healing strains) from exacerbation and potentiation of Lm infection.",
            "startOffset": 29687,
            "title": "Introduction"
        },
        {
            "endOffset": 44425,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0095",
            "sentence": "Analyses of all three strains of mice were plotted as a function of the average percent change of 3 mice from each strain from standard control results (arbitrarily set at 100%) from unvaccinated mice (Fig. 5; panel B-1 and B-2).",
            "startOffset": 44196,
            "title": "MAX-CLDC immunized mice challenged with Lm + MAX have increased percentages of IFN\u03b3-secreting and decreased IL-4-secreting CD4+ cells from footpad draining lymph nodes (LNs)"
        },
        {
            "endOffset": 33107,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "refoffsets": {
                "b0080": {
                    "endOffset": 33001,
                    "startOffset": 32997
                }
            },
            "secId": "s0040",
            "sentence": "Cationic liposome-DNA complexes (CLDC) were prepared fresh immediately prior to injection by gently mixing cationic liposomes with 100 \u00b5g/ml of plasmid DNA (non-coding pDNA, vector 75.6) in 1.0 ml sterile 1mM Tris-buffered 5% dextrose in water at room temperature [16] along with either 50 \u00b5g of FL-MAX or 5\u201350 \u00b5g each of 11 peptides spanning the entire 63 AA length of MAX.",
            "startOffset": 32733,
            "title": "Preparation of CLDC and alhydrogel\u00ae adjuvants and combination with MAX Ags"
        },
        {
            "endOffset": 34247,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Two weeks following the boost, mice were challenged with a low Lm dose (102 to 103) with or without 10 ng MAX.",
            "startOffset": 34137,
            "title": "Immunizing against MAX and Lm challenges"
        },
        {
            "endOffset": 33298,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "To prepare the aluminum hydroxide (alum) vaccine, 50 \u00b5g of FL-MAX was admixed with 2% (w/v) Alhydrogel\u00ae (InvivoGen, San Diego, CA) at 2 mg FL-MAX per mg of alum in phosphate buffered saline.",
            "startOffset": 33108,
            "title": "Preparation of CLDC and alhydrogel\u00ae adjuvants and combination with MAX Ags"
        },
        {
            "endOffset": 36558,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "refoffsets": {
                "b0020": {
                    "endOffset": 36557,
                    "startOffset": 36551
                },
                "b0095": {
                    "endOffset": 36557,
                    "startOffset": 36551
                }
            },
            "secId": "s0065",
            "sentence": "Cultures of bone marrow cells from BALB/c or C3H mice were established as described [4,19].",
            "startOffset": 36467,
            "title": "Isolation of DCs from in vitro cultures of bone marrow cells"
        },
        {
            "endOffset": 47181,
            "parents": [],
            "secId": "s0100",
            "sentence": "Salivary components increase parasite infectivity using various vector/pathogen combinations in vivo: Lu.",
            "startOffset": 47076,
            "title": "Discussion"
        },
        {
            "endOffset": 50558,
            "parents": [],
            "secId": "s0100",
            "sentence": "Hence, antibodies targeting this domain would likely act as antagonists to MAX receptor binding.",
            "startOffset": 50462,
            "title": "Discussion"
        },
        {
            "endOffset": 45753,
            "parents": [],
            "secId": "s0100",
            "sentence": "However this approach was proper for these experiments in order to best recapitulate natural infection processes.",
            "startOffset": 45640,
            "title": "Discussion"
        },
        {
            "endOffset": 40614,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "Vaccination with CLDC containing an irrelevant protein antigen (Hen egg lysozyme (HEL) did not improve parasite burden in any mouse strain (Data not shown).",
            "startOffset": 40458,
            "title": "Reduced parasite burden in footpads from peptide-vaccinated mice 9 and 18 weeks post low-dose Lm+MAX challenge"
        },
        {
            "endOffset": 47238,
            "parents": [],
            "refoffsets": {
                "b0135": {
                    "endOffset": 47205,
                    "startOffset": 47201
                },
                "b0140": {
                    "endOffset": 47233,
                    "startOffset": 47226
                },
                "b0145": {
                    "endOffset": 47233,
                    "startOffset": 47226
                },
                "b0150": {
                    "endOffset": 47233,
                    "startOffset": 47226
                }
            },
            "secId": "s0100",
            "sentence": "longipalpis and Lm [27], P. papatasi and Lm [28\u201330], Lu.",
            "startOffset": 47182,
            "title": "Discussion"
        },
        {
            "endOffset": 31457,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Animal protocols and procedures were approved by the Colorado State University Institutional Animal Care and Use Committee (protocol # 12-3413A).",
            "startOffset": 31312,
            "title": "Mice"
        },
        {
            "endOffset": 31844,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Synthetic full-length maxadilan and 15 AA over-lapping peptides thereof were prepared by Twenty-first Century Biochemicals, Inc. (Marlboro, MA).",
            "startOffset": 31700,
            "title": "Synthetic maxadilan and MAX peptides"
        },
        {
            "endOffset": 46245,
            "parents": [],
            "secId": "s0100",
            "sentence": "This was consistent for two separate experiments spanning a total of 10 mice.",
            "startOffset": 46168,
            "title": "Discussion"
        },
        {
            "endOffset": 40457,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "For all three strains, the most protective CLDC adjuvanted vaccines were those containing either the FL MAX or the P11 peptide.",
            "startOffset": 40330,
            "title": "Reduced parasite burden in footpads from peptide-vaccinated mice 9 and 18 weeks post low-dose Lm+MAX challenge"
        },
        {
            "endOffset": 40329,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "Moreover, all strains of mice immunized with CLDC containing P1, P2, or P11 Ag peptides demonstrated decreases in parasite burden after 9 or 18 weeks post challenge when compared to unvaccinated controls (Fig. 2).",
            "startOffset": 40116,
            "title": "Reduced parasite burden in footpads from peptide-vaccinated mice 9 and 18 weeks post low-dose Lm+MAX challenge"
        },
        {
            "endOffset": 42745,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "PACAP6-38 partially blocked the MAX effect on CD80 expression on BM-DCs from C57BL/6 mice (Fig. 4A, CD80 panel).",
            "startOffset": 42633,
            "title": "Serum antibodies from BALB/c, C57BL/6 and C3H immunized with the P11 CLDC recognize both FL MAX and the P11 peptide and neutralized MAX-mediated DC reprograming in vitro"
        },
        {
            "endOffset": 42846,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "However, PACAP6-38 effectively blocked the MAX mediated up-regulation of CD86 (Fig. 4B, CD86 panel).",
            "startOffset": 42746,
            "title": "Serum antibodies from BALB/c, C57BL/6 and C3H immunized with the P11 CLDC recognize both FL MAX and the P11 peptide and neutralized MAX-mediated DC reprograming in vitro"
        },
        {
            "endOffset": 30939,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "5\u20136 week old (25 g) female BALB/c, C3H-HeN and C57BL/6 mice were obtained from National Cancer Institute (Frederick, MD).",
            "startOffset": 30818,
            "title": "Mice"
        },
        {
            "endOffset": 39902,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "Co-injection of Lm + MAX resulted in increased parasite burden in mice compared to those challenged with Lm alone.",
            "startOffset": 39788,
            "title": "Reduced parasite burden in footpads from peptide-vaccinated mice 9 and 18 weeks post low-dose Lm+MAX challenge"
        },
        {
            "endOffset": 30320,
            "parents": [],
            "secId": "s0005",
            "sentence": "Furthermore, we have located a single peptide (P11) comprising the C-terminal 15 AA in MAX that, in the context of the CLDC adjuvant, effectively neutralizes the disease-enhancing effect of MAX.",
            "startOffset": 30126,
            "title": "Introduction"
        },
        {
            "endOffset": 44534,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0095",
            "sentence": "The overall increased percentage ratio of IFN\u03b3- vs. IL-4-producing CD4+ in MAX-CLDC-immunized mice was 2.53.",
            "startOffset": 44426,
            "title": "MAX-CLDC immunized mice challenged with Lm + MAX have increased percentages of IFN\u03b3-secreting and decreased IL-4-secreting CD4+ cells from footpad draining lymph nodes (LNs)"
        },
        {
            "endOffset": 33404,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "The mixture was allowed to rock for 60 min on rocking platform at RT and administered to mice within 3 h.",
            "startOffset": 33299,
            "title": "Preparation of CLDC and alhydrogel\u00ae adjuvants and combination with MAX Ags"
        },
        {
            "endOffset": 47490,
            "parents": [],
            "secId": "s0100",
            "sentence": "Thus, exposure to vector salivary components alter host hemostasis and/or immune responses, suggesting these mechanisms are general and conserved in nature.",
            "startOffset": 47334,
            "title": "Discussion"
        },
        {
            "endOffset": 45267,
            "parents": [],
            "secId": "s0100",
            "sentence": "We demonstrated that FL-MAX, C- and N- terminal peptides thereof can be utilized as Ag, without parasite components, in a liposome/DNA adjuvant vaccine system protecting three strains of mice from potentiation and exacerbation of Lm infection.",
            "startOffset": 45024,
            "title": "Discussion"
        },
        {
            "endOffset": 34068,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and Methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Other groups of control mice (n = 5\u20138) were immunized with CLDC complexed with the irrelevant control antigen, hen egg lysozyme (HEL), (Sigma Aldrich, St. Louis, MO), or were sham-injected with adjuvant or antigen alone.",
            "startOffset": 33848,
            "title": "Immunizing against MAX and Lm challenges"
        },
        {
            "endOffset": 29546,
            "parents": [],
            "secId": "s0005",
            "sentence": "Furthermore, in the case of disease transmission by Lu.",
            "startOffset": 29491,
            "title": "Introduction"
        },
        {
            "endOffset": 38336,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "Fig. 1 shows the comparative kinetics of lesion swelling over 18 weeks between P1, P2 and P11 vaccinated and unvaccinated control mice (compare solid lines, open circles and open triangles in Fig. 1, panels B, C and D for P1-, P2- and P11-CLDC results).",
            "startOffset": 38083,
            "title": "Footpad lesions show comparative improvement in Lm+MAX-challenged mice vaccinated with CLDC containing peptides from FL MAX or 15 AA peptides from N- or C- terminal regions of MAX"
        },
        {
            "endOffset": 42345,
            "parents": [
                {
                    "id": "s0075",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0020": {
                    "endOffset": 42335,
                    "startOffset": 42332
                }
            },
            "secId": "s0090",
            "sentence": "Additionally, treatment of synthetic MAX with anti-MAX P11 (1%) antisera prior to addition to in vitro cultures of BM-DCs effectively blocked the MAX effect of abrogating the up-regulation of CD80 on LPS-stimulated BM-DCs as previously observed [4] (Fig. 4).",
            "startOffset": 42087,
            "title": "Serum antibodies from BALB/c, C57BL/6 and C3H immunized with the P11 CLDC recognize both FL MAX and the P11 peptide and neutralized MAX-mediated DC reprograming in vitro"
        }
    ],
    "docId": "S0264410X17314470",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": "william.wheat@colostate.edu",
                "first": "William H.",
                "initial": "W.H.",
                "last": "Wheat"
            },
            {
                "email": null,
                "first": "Erik N.",
                "initial": "E.N.",
                "last": "Arthun"
            },
            {
                "email": null,
                "first": "John S.",
                "initial": "J.S.",
                "last": "Spencer"
            },
            {
                "email": null,
                "first": "Daniel P.",
                "initial": "D.P.",
                "last": "Regan"
            },
            {
                "email": null,
                "first": "Richard G.",
                "initial": "R.G.",
                "last": "Titus"
            },
            {
                "email": null,
                "first": "Steven W.",
                "initial": "S.W.",
                "last": "Dow"
            }
        ],
        "doi": "10.1016/j.vaccine.2017.10.039",
        "firstpage": "6611",
        "issn": "0264410X",
        "keywords": [
            "Adjuvants",
            "Cationic Lipid DNA complexes, CLDC",
            "Leishmania",
            "Maxadilan",
            "Saliva",
            "Sand flies",
            "Vaccine"
        ],
        "lastpage": "6619",
        "openaccess": "Full",
        "pub_year": 2017,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Immunization against full-length protein and peptides from the Lutzomyia longipalpis sand fly salivary component maxadilan protects against Leishmania major infection in a murine model"
    }
}